Showing 1 - 20 results of 34 for search '"epithelial ovarian cancer"', query time: 0.09s Refine Results
  1. 1

    Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer by Elizabeth T. Evans, Emily F. Page, Alex Seok Choi, Zainab Shonibare, Andrea G. Kahn, Rebecca C. Arend, Karthikeyan Mythreye

    Published 2024-09-01
    “…Abstract Objective The TGF‐β superfamily member activin, a dimer of the gene products of INHBA and/or INHBB, has been implicated in immune cell maturation and recruitment, but its immune impact within epithelial ovarian cancer (EOC) is not well characterized. …”
    Get full text
    Article
  2. 2
  3. 3

    Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer by Renee Vermeij, Toos Daemen, Geertruida H. de Bock, Pauline de Graeff, Ninke Leffers, Annechien Lambeck, Klaske A. ten Hoor, Harry Hollema, Ate G. J. van der Zee, Hans W. Nijman

    Published 2010-01-01
    “…The prognosis of epithelial ovarian cancer (EOC), the primary cause of death from gynaecological malignancies, has only modestly improved over the last decades. …”
    Get full text
    Article
  4. 4

    The Impact of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Epithelial Ovarian Cancer by Samet Kirat, Utku Akgor

    Published 2022-12-01
    Subjects: “…Epithelial ovarian cancer, Neutrophil-to-lymphocyte ratio, Platelet-to-lymphocyte ratio, Prognostic factor, Systemic inflammatory response markers…”
    Get full text
    Article
  5. 5

    Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: A Viable Option? by Christina Fotopoulou, Ioana Braicu, Jalid Sehouli

    Published 2012-01-01
    “…Epithelial ovarian cancer (EOC) continues to represent one of the most lethal conditions in women in the western countries. …”
    Get full text
    Article
  6. 6

    Predictive and Prognostic Value of sPRR in Patients with Primary Epithelial Ovarian Cancer by Katrin Kreienbring, Annika Franz, Rolf Richter, Duska Dragun, Harald Heidecke, Ralf Dechend, Dominik N. Muller, Jalid Sehouli, Elena I. Braicu

    Published 2016-01-01
    “…The purpose of the present study was to analyze the predictive and prognostic role of soluble (pro)renin receptor (sPRR) as a biomarker for clinicopathological outcome in patients with primary epithelial ovarian cancer (EOC). As part of the renin-angiotensin system (RAS) whose activity is known to increase in ovarian cancer patients, the relation of sPRR and ovarian cancer should be further investigated. …”
    Get full text
    Article
  7. 7
  8. 8

    Unlocking prognostic potential: A genomic signature of caloric restriction in patients with epithelial ovarian cancer. by Ori Tal, Tamar Zahavi, Liat Anabel Sinberger, Mali Salmon-Divon

    Published 2025-01-01
    “…<h4>Objectives</h4>Epithelial ovarian cancer is a significant contributor to cancer-related mortality in women, frequently recurring post-treatment, often accompanied by chemotherapy resistance. …”
    Get full text
    Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Expression of Semaphorin 3F and Its Receptors in Epithelial Ovarian Cancer, Fallopian Tubes, and Secondary Müllerian Tissues by Christina D. Drenberg, Sandra Livingston, Ren Chen, Patricia A. Kruk, Santo V. Nicosia

    Published 2009-01-01
    “…While semaphorins and their receptors appear to play a role in tumor carcinogenesis, little is known about the role of semaphorin 3F (S3F) in epithelial ovarian cancer (EOC) development. Therefore, we sought to determine the clinical relationship between S3F and its receptors, neuropilin-2 (NP-2) and neuropilin-1 (NP-1) with EOC progression. …”
    Get full text
    Article
  15. 15

    Prognostic Factors and a Predictive Nomogram of Cancer-Specific Survival of Epithelial Ovarian Cancer Patients with Pelvic Exenteration Treatment by Ting Wang, Xin Fu, Lei Zhang, Shuna Liu, Ziqi Tao, Fang Wang

    Published 2023-01-01
    “…The aim of this study was to explore prognostic factors, develop and internally validate a prognostic nomogram model, and predict the cancer-specific survival (CCS) of epithelial ovarian cancer (EOC) patients with pelvic exenteration (PE) treatment. …”
    Get full text
    Article
  16. 16

    Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer by Marianne J. Rutten, Gabe S. Sonke, Anneke M. Westermann, Willemien J. van Driel, Johannes W. Trum, Gemma G. Kenter, Marrije R. Buist

    Published 2015-01-01
    “…Although complete debulking surgery for epithelial ovarian cancer (EOC) is more often achieved with interval debulking surgery (IDS) following neoadjuvant chemotherapy (NACT), randomized evidence shows no long-term survival benefit compared to complete primary debulking surgery (PDS). …”
    Get full text
    Article
  17. 17
  18. 18

    Ultrasonic radiomics-based nomogram for preoperative prediction of residual tumor in advanced epithelial ovarian cancer: a multicenter retrospective study by Shanshan Li, Qiuping Ding, Lijuan Li, Yuwei Liu, Hanyu Zou, Yushuang Wang, Xiangyu Wang, Bingqing Deng, Qingxiu Ai

    Published 2025-02-01
    “…ObjectivesTo identify radiomic features extracted from ultrasound images and to develop and externally validate a comprehensive model that combines clinical data with ultrasound radiomics features to predict the residual tumor status in patients with advanced epithelial ovarian cancer (OC).MethodsThe study included 112 patients with advanced epithelial OC who underwent preoperative transvaginal ultrasound. …”
    Get full text
    Article
  19. 19
  20. 20